Seattle Genetics Inc Reaches Analyst Target Price
August 20, 2018 at 07:54 AM EDT
In recent trading, shares of Seattle Genetics Inc (SGEN) have crossed above the average analyst 12-month target price of $74.30, changing hands for $74.64/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..